iopromide 370 mg / mL Injection 200 mL (Ultravist)
Comprehensive product details for sourcing and verification.
| NDC 11 | 50419-0346-20 |
|---|---|
| Product NDC | 50419-0346 |
| Generic Drug Name | iopromide |
| Brand Name | Ultravist |
| Manufacturer | Bayer HealthCare Pharmaceuticals Inc. |
| Strength | 370 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intra-Arterial; Intravenous |
| Package Quantity | 10 Vial, Glass |
| Package Description | 10 VIAL, GLASS in 1 CARTON (50419-346-20) / 200 mL in 1 VIAL, GLASS |
| Active Ingredients | Iopromide |
| Marketing Category | NDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
iopromide 370 mg / mL Injection is tracked under NDC 50419-0346-20 and rolls up into product family 50419-0346. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 10 Vial, Glass.
- Manufacturer: Bayer HealthCare Pharmaceuticals Inc..
- Dosage form: Injection.
- Family size: 10 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Public sources include public shortage-history links for Ultravist (iopromide) centered on the 2022 iodinated contrast media shortage and FDA-authorized foreign-labeled supply.
Drug Shortage Index family
View Iopromide in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Iopromide.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
iopromide 370 mg / mL Injection 200 mL (Ultravist), NDC 50419-0346-20, is a Bayer HealthCare Pharmaceuticals Inc. 370 mg / mL injection presentation packaged as 10 Vial, Glass. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 50419-0346-20.
- Digits-only NDC 11: 50419034620.
- Possible 10-digit display format: 50419-346-20 (5041934620).
Helpful product links
- Search by brand name: Ultravist.
- Exact NDC 11: 50419-0346-20.
- Product family NDC: 50419-0346.
- Other package sizes in this family: 10 Bottle.
- Compare related presentations: iopromide 370 mg / mL Injection 100 mL (Ultravist), iopromide 370 mg / mL Injection 100 mL (Ultravist), iopromide 370 mg / mL Injection 150 mL (Ultravist), iopromide 370 mg / mL Injection 200 mL (Ultravist), iopromide 370 mg / mL Injection 200 mL (Ultravist).
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.